|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Although myocardial dysfunction after resuscitation from ventricular fibrillation (VF) has been extensively investigated, less is known of the function of the myocardium after asphyxial cardiac arrest. The present experimental study was designed to compare postresuscitation left ventricular (LV) function after cardiac arrest caused by asphyxia with that of cardiac arrest induced by dysrhythmia. Four groups of Sprague-Dawley rats, which included eight animals in each group, were investigated. In the first two groups, cardiac arrest followed asphyxia produced by neuromuscular blockade with and without airway obstruction. In a third group, cardiac arrest was induced by electrical fibrillation of the ventricle. The fourth group represented animals in which the duration of asphyxial cardiac arrest was maintained for a time interval corresponding to that of the VF group. The fourth group received approximately the same number of electrical shocks as the third (VF) group. All animals were successfully resuscitated with precordial compression and mechanical ventilation. Postresuscitation measurements, including cardiac output, LV end-diastolic pressure (LVEDP), rate of pressure rise at LV pressure of 40 mm Hg (LV dP/dt40), and negative LV dP/dt, demonstrated decreased myocardial function in each group. No differences in cardiac function were observed between the animals with primary respiratory arrest whether or not the airway was obstructed. However, disproportionate and consistently greater impairment in myocardial function followed primary cardiac arrest due to VF when compared with equal duration of asphyxial cardiac arrest. We conclude that in this healthy animal model, asphyxial cardiac arrest resulted in significantly lesser impairment of postresuscitation myocardial function when compared with cardiac arrest caused by VF.
| |
INTRODUCTION |
|---|
|
|
|---|
Keywords: cardiac arrest; ventricular fibrillations; asphyxia; myocardial function
Experimental and clinical investigations now support the notion that deaths after initially successful resuscitation from ventricular tachycardia or ventricular fibrillation (VF), at least in part, are caused by postresuscitation impairment in myocardial function (1). This contrasts with patients who present with extremes of bradycardia or asystole in whom there is more often a primary respiratory or neural cause for cardiac arrest (7). Asphyxial causes of cardiac arrest, resulting from airway obstruction or failure of ventilation, account for the vast majority of instances of cardiac arrest in pediatric victims (8). Suboptimal exchange of oxygen and carbon dioxide is associated with progressive hypoxemia, hypercarbia, bradycardia, hypotension, and loss of consciousness before pulselessness. The onset of asphyxial cardiac arrest is therefore more gradual in contrast to the pulselessness, loss of consciousness, and apnea after the sudden onset of VF, which is the predominant cause of cardiac arrest in older adults (9).
In the present study, we sought to compare postresuscitation myocardial function and duration of survival in animals in which cardiac arrest was induced by VF and animals in which cardiac arrest followed asphyxiation caused by apnea. Additional studies were performed in which the duration of asphyxial cardiac arrest was adjusted to correspond to the duration of cardiac arrest in the VF group and in which the animals received a comparable number of electrical shocks.
| |
METHODS |
|---|
|
|
|---|
Animals received humane care following approval of the Institute of Critical Care Medicine's Animal Use and Care Committee, and in compliance with the Principles of Laboratory Animal Care formulated by the National Society for Medical Research and the Guide for the Care and Use of Laboratory Animals prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health. Our Institute is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care.
Animal Preparation
Male Sprague-Dawley breeder rats, weighing between 450 and 550 g, were fasted overnight except for free access to water. Anesthesia was initiated by intraperitoneal injection of 45 mg/kg pentobarbital sodium and supplemented with additional hourly doses of 10 mg/kg. Animals were placed on a surgical board in a supine position with extremities immobilized. The trachea was orally intubated with a 14-gauge cannula (Abbocath-T; Abbott Hospital Products, North Chicago, IL) mounted on a blunt needle by techniques previously described (13).
From the surgically exposed right carotid artery, an 18-gauge polyethylene catheter (Intramedic PE50; Becton Dickinson, Sparks, MD) was advanced into the left ventricle for measurement of left ventricular (LV) pressure and both rate of pressure rise at LV pressure of 40 mm Hg (dP/dt40) and rate of pressure decrease (negative dP/dt). An 18-gauge polyethylene catheter was advanced through the left external jugular vein into the right atrium for injection of thermal tracer. A 3-French pediatric radial arterial catheter (C-PUM-301J; Cook Critical Care, Ellettsville, IN) was advanced from the right external jugular vein into the right atrium. Two additional Intramedic PE50 catheters were advanced through the surgically exposed left femoral artery and vein into the abdominal aorta and into the inferior vena cava for measurements of arterial pressures and for arterial and venous blood sampling. Cardiac output was measured with a thermocouple microprobe (number 9030-12-34; Columbus Instruments, Columbus, OH), which was advanced through the right femoral artery into the thoracic aorta. Blood temperature was monitored with this sensor and maintained between 36.5° C and 37.5° C with the aid of infrared heating lamps. End-tidal PCO2 (EtPCO2) was measured with a side-stream infrared CO2 analyzer (End-Tid IL 200; Instrumentation Laboratory Inc., Lexington, MA). For animals randomized to dysrhythmic cardiac arrest, a precurved guidewire, supplied with the pediatric radial artery catheter, was advanced into the right ventricle until an endocardial electrocardiogram (ECG) was documented.
Experimental Procedures
Anesthetized animals were mechanically ventilated beginning 15 min before inducing apnea or VF, using a high-frequency jet ventilator of our
own design as previously described (13). Tidal volume was established at
0.65 ml/100 g animal weight and respiratory frequency at 100/min. For an
initial interval of 5 min of mechanical ventilation, the fraction of inspired
oxygen (FIO2) was established at 1.0, and baseline blood gases were measured. The interval was to obtain baseline values that would be comparable to those obtained after resuscitation when animals were also returned
to an FIO2 of 1.0. After baseline measurements were completed, the FIO2
was decreased to 0.21. Four groups of animals were investigated. The first
group represented apnea without airway obstruction. Mechanical ventilation was discontinued and apnea was induced after a right atrial injection
of 0.4 mg/kg pancuronium bromide (Organon Inc., West Orange, NJ).
This group was designated "NMB." In the second group, the procedure
was identical except that the endotracheal tube was occluded with a plastic
male Luer lock adapter (Baxter Healthcare Corp., Deerfield, IL). This
group was designated "NMB-O." Asphyxia was confirmed when there
was no evidence of endotracheal gas flow, on the capnogram over an interval of 4 min. In the setting of asphyxia, cardiac arrest was defined as a
mean aortic pressure decline to less than 30 mm Hg. Initial management
was restoration of mechanical ventilation with an FIO2 of 1.0. Failing to restore aortic pressure of greater than 30 mm Hg within 30 s, precordial compression was begun in addition to continued mechanical ventilation using a pneumatically driven mechanical chest compressor. Precordial compression was maintained at a rate of 200/min and synchronized to provide a compression/ventilation ratio of 2:1 with equal compression-relaxation intervals as previously described (13). Depth of compression was adjusted to decrease the anteroposterior diameter of the chest by 30% and
subsequently adjusted to secure a coronary perfusion pressure (CPP)
20 mm Hg. Our rationale for selecting different methods for producing asphyxia was to individually investigate whether there were any differences
in postresuscitation myocardial function after respiratory arrest induced
by apnea alone or apnea/asphyxia associated with airway obstruction.
The third group represented cardiac arrest resulting from VF. VF was induced with delivery of an alternating current of 2 to 6 mA to the right ventricular endocardium as previously described (3, 6, 13). Four minutes after onset of VF, precordial compression and mechanical ventilation were started and continued for 2 min. Defibrillation was then attempted with a 2-J DC shock delivered between the anterior chest and conductive foil in contact with the skin of the posterior thorax. Failing to reverse VF, precordial compression was resumed for an additional interval of 30 s, followed by a second sequence of three shocks. A third sequence of defibrillatory shocks was attempted if VF persisted after an additional 30 s of precordial compression. In the fourth group, apnea was induced to produce cardiac arrest in an identical fashion to that of the NMB group. Cardiac arrest was maintained for an interval comparable to that of the VF group. Because investigations in our laboratory had demonstrated that electrical shocks of themselves adversely affect postresuscitation myocardial function (6), approximately the same number and energy of electrical shocks were delivered over comparable intervals to these animals (NMB-E) during resuscitation even though these animals maintained a regular rhythm.
Resuscitation was defined as the reestablishment of a mean aortic pressure of 60 mm Hg or greater for an interval exceeding 5 min. Hemodynamic measurements and mechanical ventilation with an FIO2 of 1.0 were continued for a total of 4 h. The endotracheal tube and catheters were then removed. After recovery from anesthesia, animals were returned to their cages, and physical activity and survival were recorded at 24-h intervals for a total of 72 h.
After 72 h, the animals were euthanized with an intraperitoneal injection of 100 mg/kg of pentobarbital. Autopsy was performed on all animals with gross inspection of thoracic and abdominal organs to identify potential adverse effects of the resuscitative interventions.
Measurements
Blood was sampled in amounts of 0.4 ml from the aorta and the inferior vena cava for laboratory measurement, and an equal quantity of blood was transfused into the left femoral vein from an anesthetized donor rat of the same colony as previously described (13). Aortic and central venous blood pH, PCO2, and PO2, and lactate were measured with a Stat Profile Ultra (Nova Biomedical Co, Waltham, MA). ECG limb leads II and aVR were recorded with the aid of needle electrodes. Cardiac output was measured with the thermodilution technique in which a bolus of 200 µl of saline at a temperature of between 10 and 15° C was injected into the right atrium. Cardiac index was computed with an adaptation of a commercially available data acquisition system and software (National Instruments, Austin, TX). Aortic, LV, and right atrial pressures, ECG, and PETCO2 were recorded on a PC-based data acquisition system using CODAS software (DATAQ Instruments, Akron, OH) at a sampling rate of 300/s as previously described (3, 6, 13). CPP was calculated as the difference between (decompression) diastolic aortic pressure and time-coincident right atrial pressure as previously described.
Myocardial function was assessed from measurements of LV pressure. The rate of LV pressure increase was measured at a LV pressure of 40 mm Hg (dP/dt40) by analog differentiation. It represents an index of isovolemic contractility. The maximal rate of LV pressure decline (
dP/dt) was measured as an estimate of myocardial relaxation.
Neurologic deficit was scored at 24, 48, and 72 h after resuscitation on a scale of 0 (fully alert and active) to 500 (nonreactive with apnea) as described by Hendrickx and coworkers (9).
Statistical Analyses
Measurements were reported as mean ± SD. Baseline measurements between groups were compared by analysis of variance (ANOVA). Time-based measurements within groups were compared by ANOVA repeated measurements. A p value of less than 0.05 was regarded as significant.
| |
RESULTS |
|---|
|
|
|---|
Thirty-four animals were investigated. Two animals randomized to the NMB group were excluded from analysis and rerandomized because retrospective review indicated that the mean aortic pressure did not decline to less than 30 mm Hg such that the animals failed to fulfill the criteria of asphyxial cardiac arrest.
Baseline hemodynamic measurements did not differ significantly among the four groups. There were also no significant differences in weight, baseline blood gases, or baseline arterial blood lactate among the four groups (Table 1).
|
Asphyxial cardiac arrest occurred approximately 170 s after injection of the neuromuscular blocking agent. The durations of asphyxial cardiac arrest in the NMB group and NMB-O group were 103 and 105 s, respectively. Ventricular fibrillation appeared in only one animal among the asphyxial groups and that animal was successfully defibrillated. Excepting this animal, there was a consistent and progressive slowing of the supraventricular rhythm from baseline levels of 371 ± 23 to 86 ± 23. In animals in which VF was induced, an average of seven electrical shocks were required before restoration of spontaneous circulation (ROSC) (Table 2). The duration of cardiopulmonary resuscitation (CPR), and specifically ventilation and precordial compression before ROSC, averaged 174 s. In the asphyxial group, ventilation and precordial compression were followed by ROSC within an average of 56 to 77 s (Table 2). All animals in the asphyxial group were resuscitated. No significant differences in postresuscitation myocardial function between NMB and NMB-O, the two initial asphyxial groups, were demonstrated based on cardiac index, dP/dt40 (Figure 1), negative dP/dt, and LV end-diastolic pressure (LVEDP) (Figure 2).
|
|
|
Because the experimental models of asphyxial cardiac arrest (NMB and NMB-O) did not take into account the longer durations of cardiac arrest observed for the VF model or the effects of electrical shocks, we were prompted to control these variables. We therefore extended our studies to include an additional model of asphyxial cardiac arrest. Durations of cardiac arrest in this model were adjusted to correspond to the average duration established in the VF model. In addition, we elected to deliver electrical shocks with energies and in numbers that corresponded to the VF model, even though the rhythm remained sinus bradycardia. In this additional group (NMB-E), cardiac index and dP/dt40 were compared with the VF group as shown in Figure 3. Postresuscitation myocardial function based on the cardiac index and dP/dt40 was significantly less impaired in the NMB-E group. Lesser impairment in myocardial relaxation, as measured by disproportionately greater negative dP/dt and significantly lower LVEDP were also documented in this modified asphyxial model (Figure 4). However, neither neurologic deficits measured at 24, 48, and 72 h in survivors (Table 3) nor the duration of survival among the four groups were significantly different (Table 2).
|
|
|
At autopsy, minor lung contusions were observed in five of 40 animals. However, there was no evidence of other adverse effects of the resuscitative interventions on thoracic and abdominal organs.
| |
DISCUSSION |
|---|
|
|
|---|
In the United States, approximately 350,000 victims annually have fatal cardiac arrest before admission to the hospital. Although the initial success of CPR on these victims is 40%, a majority die within 72 h, primarily owing to recurrent VF associated with impaired myocardial function (1, 14). In most communities, CPR for victims of cardiac arrest yields a functional survival rate of only 5%.
The clinical course that follows successful resuscitation after dysrhythmic cardiac arrest in human victims has been documented by two recent multicenter studies. Approximately 60% of victims died within the initial 72 h after successful cardiac resuscitation. Refractory hypotension and recurrent VF were identified as predominant causes of postresuscitation death (1, 2). In the Brain Resuscitation Clinical Trial I, approximately 60% of successfully resuscitated patients died during the first 10 d. Arterial hypotension and recurrent VF were again identified as the primary events (15). We have implicated reversible myocardial dysfunction after initially successful resuscitation to explain, at least in part, "postresuscitation myocardial dysfunction" (3).
In the present study, no significant differences in cardiac function, neurologic responsiveness, or duration of survival were observed between asphyxial cardiac arrest with and without airway obstruction. However, the studies were performed in anesthetized animals after neuromuscular blockade in which the effects of airway obstruction were minimal in the absence of a struggle to maintain spontaneous ventilation. Because the duration of untreated cardiac arrest, and therefore the duration of no flow, is the single best predictor of the severity of postresuscitation myocardial dysfunction, we recognized the importance of controlling this variable (3, 4). Because the severity of postresuscitation myocardial dysfunction increased in close relationship to the total energy of the electrical shocks delivered before ROSC (6), a comparable number of electrical shocks was administered to the VF and NMB-E groups. We therefore conclude that postresuscitation myocardial systolic and diastolic function of the asphyxial group (NMB-E) in which both the duration of cardiac arrest and the number of electrical shocks were adjusted, continued to be less than that observed after dysrhythmic cardiac arrest caused by VF.
In contrast to the "sudden death" of dysrhythmic cardiac arrest, conscious victims of asphyxial cardiac arrest typically manifest respiratory distress. As in our experimental model, bradycardia typically advances to pulseless electrical activity rather than VF (16, 17). Bradycardia and hypotension are also the rule in hibernating animals, and these physiologic adaptations serve to minimize systemic and myocardial oxygen requirements. During the no flow or minimal flow state of clinical cardiac arrest, bradycardia would mitigate the detriment of oxygen deficits and resultant ischemic injury to the myocardium. This is in contrast to VF in which disproportionately greater myocardial oxygen requirements account for early and marked global myocardial ischemia (18, 19). These differences in metabolic demands are likely to explain, at least in part, the greater severity of postresuscitation myocardial ischemic injury when cardiac arrest is caused by VF (20).
Our studies have focused on adverse effects on the myocardium. However, it is well documented that asphyxia results in early cerebral ischemic injury (11). Therefore, we anticipated that survival in animals after asphyxial cardiac arrest was more contingent on neurologic outcomes. Although the present study does not secure that possibility, we do not exclude the potential importance of combined myocardial and neurologic ischemic injury as a determinant of outcomes.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Max Harry Weil, M.D., Ph.D., The Institute of Critical Care Medicine, 1695 N Sunrise Way, Bldg. #3, Palm Springs, CA 92262. E-mail: weilm{at}aol.com
(Received in original form July 17, 2000 and accepted in revised form July 9, 2001).
Acknowledgments:
Supported in part by a grant from the NIH, Heart, Lung, and Blood Institute (R01
HL-54322), the Rosse Family Charitable Foundation, and the philanthropy of Mr.
and Mrs. Jack Samuelson.
| |
References |
|---|
|
|
|---|
1. Brown CG, Martin DR, Pepe P, Stueven H, Cummins RO, Gonzalez E, Jastremski M. A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital. The Multicenter High-Dose Epinephrine Study Group. N Engl J Med 1992; 327: 1051-1055 [Abstract].
2. Stiell IG, Hebert PC, Weitzman BN, Wells GA, Raman S, Stark RM, Higginson LAJ, Ahuja J, Dickinson GE. High-dose epinephrine in adult cardiac arrest. N Engl J Med 1992; 327: 1045-1050 [Abstract].
3. Tang W, Weil MH, Sun SJ, Gazmuri RJ, Bisera J. Progressive myocardial dysfunction after cardiac resuscitation. Crit Care Med 1993; 21: 1046-1050 [Medline].
4.
Tang W,
Weil MH,
Sun SJ,
Noc M,
Yang L,
Gazmuri RJ.
Epinephrine
increases the severity of postresuscitation myocardial dysfunction.
Circulation
1995;
92:
3089-3093
5. Gazmuri RJ, Weil MH, Bisera J, Tang W, Fukui M, McKee D. Myocardial dysfunction after successful resuscitation from cardiac arrest. Crit Care Med 1996; 24: 992-1000 [Medline].
6.
Xie J,
Weil MH,
Sun S,
Tang W,
Sato Y,
Jin X,
Bisera J.
High-energy
defibrillation increases the severity of postresuscitation myocardial
dysfunction.
Circulation
1997;
96:
683-688
7. Stueven HA, Aufderheide T, Waite EM, Mateer JR. Electromechanical dissociation: six years prehospital experience. Resuscitation 1989; 17: 173-182 [Medline].
8. Hickey RW, Cohen DM, Strausbaugh S, Dietrich AM. Pediatric patients requiring CPR in the prehospital setting. Ann Emerg Med 1995; 25: 495-501 [Medline].
9. Hendrickx HH, Rao GR, Safar P, Gisvold SE. Asphyxia, cardiac arrest and resuscitation in rats. I. Short term recovery. Resuscitation 1984; 12: 97-116 [Medline].
10. DeBehnke DJ, Hilander SJ, Dobler DW, Wickman LL, Swart GL. The hemodynamic and arterial blood gas response to asphyxiation: a canine model of pulseless electrical activity. Resuscitation 1995; 30: 169-175 [Medline].
11. Vaagenes P, Safar P, Moossy J, Rao G, Diven W, Ravi C, Arfors K. Asphyxiation versus ventricular fibrillation cardiac arrest in dogs. Differences in cerebral resuscitation effects--a preliminary study. Resuscitation 1997; 35: 41-52 [Medline].
12. Safar P. Ventilatory efficacy of mouth-to-mouth artificial respiration. JAMA 1958; 167: 335-341 .
13.
von Planta I,
Weil MH,
von Planta M,
Bisera J,
Bruno S,
Gazmuri RJ,
Rackow EC.
Cardiopulmonary resuscitation in the rat.
J Appl Physiol
1988;
65:
2641-2647
14. Liberthson RR, Nagel EL, Hirschman JC, Nussenfeld SR. Prehospital ventricular defibrillation: prognosis and follow-up course. N Engl J Med 1974; 291: 317-321 .
15. Brain Resuscitation Clinical Trial I Study Group. Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. N Engl J Med 1986;314:397-403.
16. Safar P, Paradis NA. Asphyxial cardiac arrest. In: Paradis NA, Halperin HR, Nowak RM, editors. Cardiac arrest. Baltimore: Williams & Wilkins; 1996. p. 702-726.
17. Berg RA, Kern KB, Otto CW, Samson RA, Sanders AB, Ewy GA. Ventricular fibrillation in a swine model of acute pediatric asphyxial cardiac arrest. Resuscitation 1996; 33: 147-153 [Medline].
18. Brown CG, Werman HA. Adrenergic agonists during cardiopulmonary resuscitation. Resuscitation 1990; 19: 1-16 [Medline].
19. Khon RM. Myocardial oxygen uptake during ventricular fibrillation and electromechanical dissociation. Am J Cardiol 1963; 11: 483-486 [Medline].
20. Xiao F, Safar P, Radovsky A. Mild protective and resuscitation hypothermia for asphyxial cardiac arrest in rats. Am J Emerg Med 1998; 16: 17-25 [Medline].
This article has been cited by other articles:
![]() |
C. McCaul, A. Kornecki, D. Engelberts, P. McNamara, and B. P. Kavanagh Positive End-Expiratory Pressure Improves Survival in a Rodent Model of Cardiopulmonary Resuscitation Using High-Dose Epinephrine Anesth. Analg., October 1, 2009; 109(4): 1202 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
The International Liaison Committee on Resuscitati The International Liaison Committee on Resuscitation (ILCOR) Consensus on Science With Treatment Recommendations for Pediatric and Neonatal Patients: Pediatric Basic and Advanced Life Support Pediatrics, May 1, 2006; 117(5): e955 - e977. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. McCaul, P. J. McNamara, D. Engelberts, G. J. Wilson, A. Romaschin, A. N. Redington, and B. P. Kavanagh Epinephrine Increases Mortality after Brief Asphyxial Cardiac Arrest in an In Vivo Rat Model Anesth. Analg., February 1, 2006; 102(2): 542 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
Part 6: Pediatric Basic and Advanced Life Support Circulation, November 29, 2005; 112(22_suppl): III-73 - III-90. [Full Text] [PDF] |
||||
![]() |
M. H. Weil, W. Tang, and J. Bisera Cardiopulmonary Resuscitation: One Size Does Not Fit All Circulation, February 18, 2003; 107(6): 794 - 794. [Full Text] [PDF] |
||||
![]() |
M. H. Weil Erratum: A Comparison of Myocardial Function After Primary Cardiac and Primary Asphyxial Cardiac Arrest Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 774 - 774. [Full Text] [PDF] |
||||
![]() |
M. J. TOBIN Critical Care Medicine in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 565 - 583. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |